Silylated biomolecule-based hydrogel for culturing cardiomyocytes and stem cells, and use of the hydrogel thereof for treating heart failure

Patent metadata

Field	Value
Publication number	US-9968681-B2
Application number	US-201214123286-A
Country	US
Kind code	B2
Filing date	Jun 4, 2012
Priority date	Jun 3, 2011
Publication date	May 15, 2018
Grant date	May 15, 2018

Abstract

The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.

First claim

The invention claimed is:

1. A kit for obtaining an aqueous composition that is usable in a method of treating heart failure, said kit comprising i) mesenchymal stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel solution which comprises a silylated biomolecule capable of forming a pH dependent self-reticulating hydrogel, wherein the hydrogel solution comprises agents which induce cardiomyocyte differentiation of the mesenchymal stem cells.

2. The kit according to claim 1 , further comprising instructions for the use of said kit in preparing a composition comprising:
i) the mesenchymal stem cells which are able to differentiate into cardiomyocytes; and
ii) the hydrogel solution comprising a silylated biomolecule;
said composition being suitable for injection into myocardium.

3. The kit according to claim 1 , wherein the silylated biomolecule is selected from the group consisting of a silylated polysaccharide, a silylated peptide a silylated protein, and an association of two different biomolecules selected from a silylated polysaccharide, a silylated peptide, and a silylated protein.

4. The kit according to claim 3 , wherein the silylated polysaccharide is selected from the group consisting of: silylated cellulose, silylated hydroxypropylmethylcellulose (HPMC), silylated hydroxyethylcellulose (HEC), silylated carboxymethylcellulose (CMC), silylated pectin, silylated chitosan and silylated hyaluronic acid.

5. The kit according to claim 1 , wherein the hydrogel solution of (ii) has undergone three weeks of reticulation and has the following rheological characteristics at a pH value of 7.4:
a compressive modulus at 5% stress from 220 to 430 Pa;
a storage modulus G′ from 235 to 450 Pa;
a loss modulus G″ from 29 to 60 Pa;
a gel point from 23.8 to 30.6 minutes.

6. A kit for the three-dimensional culture of mesenchymal stem cells which are able to differentiate into cardiomyocytes, said kit comprising i) mesenchymal stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel solution which comprises a silylated biomolecule capable of forming a pH dependent self-reticulating hydrogel, wherein the hydrogel solution comprises agents which induce cardiomyocyte differentiation of the mesenchymal stem cells.

7. The kit according to claim 6 , wherein the silylated biomolecule is selected from the group consisting of a silylated polysaccharide, a silylated peptide a silylated protein, and an association of two different biomolecules selected from a silylated polysaccharide, a silylated peptide, and a silylated protein.

8. The kit according to claim 7 , wherein the silylated polysaccharide is selected from the group consisting of: silylated cellulose, silylated hydroxypropylmethylcellulose (HPMC), silylated hydroxyethylcellulose (HEC), silylated carboxymethylcellulose (CMC), silylated pectin, silylated chitosan and silylated hyaluronic acid.

9. The kit according to claim 6 , wherein the hydrogel solution (ii) has undergone three weeks of reticulation and has the following rheological characteristics at a pH value of 7.4:
a compressive modulus at 5% stress from 220 to 15 000 Pa;
a storage modulus G′ from 235 to 10 000 Pa;
a loss modulus G″ from 29 to 1000 Pa;
a gel point from 5 to 45 minutes.

Assignees

• Weiss Pierre
• Mathieu Eva
• Guicheux Jerome
• Lemarchand Patricia
• Inst Nat Sante Rech Med
• Univ Nantes
• Chu Nantes

Inventors

• Weiss Pierre
• Mathieu Eva
• Guicheux Jérôme
• Lemarchand Patricia

Classifications

• A61K2035/124

  the cells being hematopoietic, bone marrow derived or blood cells · CPC title

• C12N2533/78

  Cellulose · CPC title

• C12N5/0657

  Cardiomyocytes; Heart cells · CPC title

• C12N2533/20

  Small organic molecules · CPC title

• C12N2533/72

  Chitin, chitosan · CPC title